Protective effects of benzisothiazolylamidines on IL-1β induced alterations in human articular chondrocyte metabolism

Inflammation

Volumn 28, Issue 4, 2004, Pages 231-235

  Panico, A M ^a   Vicini, P ^b   Massimo, G ^b   Cardile, V ^a   Gentile, B ^a   Avondo, S ^b   Vittorio, F ^a   Ronsisvalle, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b NONE

Author keywords

Glycosaminoglycans; Metalloproteinases; N (benzo d isothiazol 3 yl)amidines; Nitric oxide; Prostaglandins

Indexed keywords

AMIDINE; CARBOXYL GROUP; GLYCOSAMINOGLYCAN; INTERLEUKIN 1BETA; N BENZO[D]ISOTHIAZOL 3 YL ACETAMIDINE; N BENZO[D]ISOTHIAZOL 3 YL BENZAMIDINE; N BENZO[D]ISOTHIAZOL 3 YL PYRIDINE 2 CARBOXAMIDINE; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEOGLYCAN; STROMELYSIN; UNCLASSIFIED DRUG; BENZISOTHIAZOLE; INTERLEUKIN 1; NEUROPROTECTIVE AGENT; THIAZOLE DERIVATIVE;

ARTHRITIS; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL METABOLISM; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN CELL; IN VITRO STUDY; PHARMACOPHORE; ARTICULAR CARTILAGE; CELL SURVIVAL; CHEMISTRY; COMPARATIVE STUDY; IMMUNOLOGY; METABOLISM;

AMIDINES; CARTILAGE, ARTICULAR; CELL SURVIVAL; CELLS, CULTURED; CHONDROCYTES; HUMANS; INTERLEUKIN-1; NEUROPROTECTIVE AGENTS; THIAZOLES;

EID: 18444415437     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:IFLA.0000049048.33885.56     Document Type: Article

References (24)

1. Sokoloff, L. 1987. Osteoarthritis as a remodelling process. J. Rheumatol. 14:7-10.
2. Smith, M. D., A. Parker, P. J. Robert-Thomson, M. J. Ahern, and M. Coleman. 1998. Production of IL-1 and IL-1 RA in different stages of arthritis. Rev. Prat. 48:S16-S23.
3. Evans, C. H. and M. Stefanovic-Racic. 1996. Nitric oxide in arthritis. Methods 10:38-42.
4. Hassan, M. S., M. M. Mileva, H. S. Dweck, and L. Ronsenfeld. 1998. Nitric oxide products degrade chondroitin sulfates. Nitric Oxide 2:360-365.
5. Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: Physiology, pathophisiology, and pharmacology. Pharmacol. Rev. 43:109-142.
6. Nadaud, S. and F. Soubrier. 1995. Biologie moléculaire et génetique des NO-synthétases. C. R. Soc. Biol. 189:1025-1038.
7. Bernardeau, C., E. Dernis-Labous, H. Blanchard, D. Lamarque, and M. Breban. 2001. Nitric oxide in rheumatology. Joint Bone Spine 68:457-462.
8. Tetsuka, T., D. Daphna Iken, W. Miller, Z. Guan, L. D. Baier, and A. R. Morrison. 1996. Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells. J. Clin. Invest. 97:2051-2056.
9. Habib, A., C. Bernard, and M. Lebret. 1997. Regulation of the expression of cyclooxiygenase-2 by nitric oxide in rat peritoneal macrophages. J. Immunol. 158:3845-3851.
10. Sapolsky, A., H. Kaiser, D. S. Howell, and J. F. Woesser. 1976. Metalloproteinases of human articular cartilage that digest cartilage proteoglycan at neutral and acid. Ph. J. Clin. Invest. 58:1030-1041.
11. Martel-Pelletier, J., J. P. Pelletier, J. M. Cloutier, D. S. Howell, L. Ghandur, and J. F. Mnaymneh. 1984. Neutral proteases capable of proteoglycan digesting activity in osteoarthritic and normal human articular cartilage. Arthritis Rheum. 27:305-312.
12. Werb, Z. 1992. The biologic role of metalloproteinases and their inhibitors. In: Articular Cartilage and Osteoarthritis, K. E. Kuettner, ed. Raven Press, New York, pp. 295-304.
13. Nguyen, Q., G. Murphy, P. J. Roughley, and J. S. Mort. 1989. Degradation of proteoglycan aggregate by a cartilage metalloproteinase. Evidence for the involvement of stromelysin in the generation of link protein heterogeneity in situ. Biochem. J. 259:61-67.
14. Vicini, P., L. Amoretti, B. Ballabeni, E. Barocelli, and M. Chiavarini. 1993. Synthesis and preliminary pharmacological study of new amidinobenzisothiazoles. Eur. J. Med. Chem. 28:955-961.
15. Panico, A. M., P. Vicini, M. Incerti, V. Cardile, B. Gentile, and G. Ronsisvalle. 2002. Amidinobenzisothiazole derivatives with antidegenerative activity on cartilage. Il. Farmaco. 57:671-675.
16. Amin, A. R., M. Attur, and R. N. Patel. 1997. Superinduction of cyclooxygenase 2 activity in human osteoarthritis affected cartilage. J. Clin. Invest. 99:1231-1237.
17. Henrotin, Y. E., S. X. Zheng, G. P. Deby, A. H. Labasse, J. M. R. Crielaard, and J. Y. L. Reginster. 1998. Nitric oxide down-regulates interleukin 1b (IL-1b) stimulated IL-6, IL-8, and prostaglandin E2 production by human chondrocytes. J. Rheumatol. 25:1595-1601.
18. Vicini, P., L. Amoretti, B. Ballabeni, E. Barocelli, and M. Chiavarini. 1995. Synthesis and study of antiphlogistic, analgesic, antipyretic and spasmolytic activities of amidinobenzisothiazole derivatives. Eur. J. Med. Chem. 30:809-814.
19. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
20. 15N] nitrate in biological fluids. Anal. Biochem. 126:131-138.
21. Farndale, R. W., C. A. Sayers, and A. J. Barrett. 1989. A direct spectrophotometric microassay for sulphated glycosaminoglycans in cultured cartilage. Connect. Tissue Res. 2:247-248.
22. Stone, J. E., N. Akttar, S. Botchway, and C. A. Pennock. 1994. Interaction of 1,9-dimethylmethylene blue with glycosaminoglycans. Ann. Clin. Biochem. 31:147-152.
23. Di Battista, J., S. Dore, J. Martel-Pellettier, and J. P. Pelletier. 1997. Human chondrocytes cell lines from articular cartilage of metatarsal phalangeal joints. Mol. Cell Endocrinol. 123:27-35.
24. 2. Exp. Cell Res. 206:58-62.